Tuesday, June 03, 2008

Redefining the CRO

Date: 5/7/2008
Length: 00:13:29
Size: 6.17MB

Thought Leader: Bob Burford Ph.D., Managing Director, Aptuit Consulting

In this episode, we discuss the relationship between drug developers and CROs, including current market conditions, the changing needs of drug developers, how to choose an outsourcing provider, expectations of a CRO, and the future of this important relationship.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Counter-Launch Planning: Pre-empting and Protecting Against Competitive Product Launches

Date: 5/6/2008
Length: 00:10:33
Size: 4.83MB

Thought Leader: Stan Bernard, M.D., MBA, President, Bernard Associates LLC

Dr. Bernard discusses the underutilized concept of Counter Launch Planning (CLP) for protecting an established brand, including what it is, why it's important, who participates in the process, how it differs from traditional marketing and war games, and finally, important execution considerations.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Precommercial Marketing and Planning: Securing Future Success through Meaningful Differentiation

Date: 4/30/2008
Length: 00:10:58
Size: 5.02MB

Thought Leader: Laurie Lucas, Founder and Principal, L3 Healthcare Marketing LLC

This Podcast covers several issues related to starting the marketing sequence earlier in the development cycle, including the differences between precommercial marketing and traditional product marketing, who the stakeholders are, what the necessary activities are, and some best practices for these activities.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.